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Abstract
Introduction: When measured using the computer-assisted method CUMULUS, mammographic density adjusted
for age and body mass index predicts breast cancer risk. We asked if new mammographic density measures
defined by higher brightness thresholds gave better risk predictions.
Methods: The Korean Breast Cancer Study included 213 women diagnosed with invasive breast cancer and 630
controls matched for age at full-field digital mammogram and menopausal status. Mammographic density was
measured using CUMULUS at the conventional threshold (Cumulus), and in effect at two increasingly higher
thresholds, which we call Altocumulus and Cirrocumulus, respectively. All measures were Box-Cox transformed and
adjusted for age, body mass index, menopausal status and machine. We used conditional logistic regression to
estimate the change in Odds PER standard deviation of transformed and Adjusted density measures (OPERA). The
area under the receiver operating characteristic curve (AUC) was estimated.
Results: Corresponding Altocumulus and Cirrocumulus density measures were correlated with Cumulus measures
(r approximately 0.8 and 0.6, respectively). Altocumulus and Cirrocumulus measures were on average 25 % and
80 % less, respectively, than the Cumulus measure. For dense area, the OPERA was 1.18 (95 % confidence interval:
1.01−1.39, P = 0.03) for Cumulus; 1.36 (1.15−1.62, P < 0.001) for Altocumulus; and 1.23 (1.04−1.45, P = 0.01) for
Cirrocumulus. After fitting the Altocumulus measure, the Cumulus measure was no longer associated with risk. After
fitting the Cumulus measure, the Altocumulus measure was still associated with risk (P = 0.001). The AUCs for dense
area was 0.59 for the Altocumulus measure, greater than 0.55 and 0.57 for the Cumulus and Cirrocumulus measures,
respectively (P = 0.001). Similar results were found for percentage dense area measures.
Conclusions: Altocumulus measures perform better than Cumulus measures in predicting breast cancer risk, and
Cumulus measures are confounded by Altocumulus measures. The mammographically bright regions might be
more aetiologically important for breast cancer, with implications for biological, molecular, genetic and
epidemiological research and clinical translation.
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Introduction
Historically, the incidence and prevalence of breast can-
cer has been lower in Asian countries than Western
countries [1, 2]. However, this is changing rapidly with
economic development over the past few decades and is
expected to increase over the next 20 years [3, 4]. Identi-
fication of predictors of risk for Asian women could be
an important tool in breast cancer control, especially if
they can be readily measured.
Mammographic density is one of strongest risk factors
for breast cancer [5, 6]. Conventionally, it has been defined
by the white or bright, as distinct from dark, areas on a
mammogram. A well-established measurement uses the
computer-assisted thresholding method CUMULUS, in
which the observer visually selects a pixel threshold to de-
fine the dense areas for each particular mammogram [7–9].
In establishing the evidence for mammographic dens-
ity as a predictor of disease [5, 10], considerable and
warranted attention has been made to having observers
‘see’ density in a similar and repeatable way. New ob-
servers have been trained to ensure comparability and
repeatability with previous observers to measure what
has conventionally been referred to as the ‘mammogra-
phically dense’ regions of the breast.
Multiple studies of Western women, and a few of
Asian women, have shown that, after adjusting for age
and body mass index (BMI), the standard measure of
mammographic density above predicts breast cancer risk
[11–16]. It is important to adjust for age and BMI be-
cause these mammographic density measures decrease
with increasing age, and with increasing BMI, yet breast
cancer risk increases with these factors [17, 18].
We used a Korean case-control study to assess if using
in effect a higher than conventional pixel threshold to
define density better discriminates cases from controls,
i.e. better predicts risk of breast cancer. We assessed the
relative discrimination by fitting the density measures
based on different degrees of brightness both independ-
ently, and together.
We also represented the strength of association for
each measure by a new approach, Odds PER Adjusted
standard deviation (OPERA), which considers risk gradi-
ents for measured variables as a function not of the
standard deviation of the unadjusted risk factor, as has
been conventional practice, but of the standard deviation
of that factor after adjusting for all other factors taken
into consideration, either by design or analysis, in the
case-control comparison [6]. The reason for this is that
the correct interpretation of a risk estimate is the change
per unit of that factor holding all other factors constant.
Therefore it is obvious that the risk per unadjusted
standard deviation is not the appropriate scale, which
should be based on the distribution of that risk factor
once it has been adjusted for all relevant covariates.
Methods
Subjects
As previously described [19], cases and controls were
selected from women who underwent a periodic health
checkup at the Health Promotion Center in the
Samsung Medical Center, Korea, between February 2006
and December 2011. Breast cancer cases were selected
based on a medical record review after breast cancer
screening with a mammogram. For each breast cancer
case, we chose approximately three controls matched for
age (within 1 year), menopausal status, and date of
health examination (within 1 month) randomly selected
from women who had undergone the same routine
health checkup. All controls had no evidence of malig-
nant disease for at least 1 year after the routine health
checkup. This study involved 213 breast cancer cases
and 630 matched controls. The median age at mammog-
raphy was 51.5 years and 45 % were under the age of
50 years. This study was approved by the Institutional
Review Board of Samsung Medical Center (2011-
0013545 and 2014R1A2A2A01002705) [19]. All women
gave written consent [19].
Mammographic density measurements
Mammographic images were obtained using the proc-
essed full-field digital mammography system (Senograph
2000D/DMR/DS, General Electric Company, Milwaukee,
WI, USA or Selenia, Hologic Inc., Marlborough, MA,
USA) in the same institution. We used the cranio-caudal
(CC) view of the breast, and for cases, the breast contra-
lateral to that involved in the cancer diagnosis. All mea-
sures were conducted in sets of 100, plus a 10 % random
repeat sample from within the set (to estimate the intra-
class correlation within a set), and in every fifth set, plus
the 10 % random sample from the first set (to estimate
the intra-class correlation between sets). All measure-
ments were blinded to case-control status as in [19] and
blinded to the previous measures.
Mammographic density was measured first using the
conventional approach for defining dense areas, and we
call those measures Cumulus, and they were conducted
by TLN, YKA, and CEF. The black or dark areas are not
included. TLN’s measures were used in our previous
publication [19].
Two of the same observers, TLN and YKA, re-
measured all mammograms. This time the observers
chose the bright, as distinct from white, areas to be
‘dense’ and therefore in effect defined mammographic
density at a higher threshold. The grayish areas that are
usually selected when measuring Cumulus were not in-
cluded. We call these latter measures Altocumulus. TLN
then measured all mammograms using in effect an even
higher level of pixel intensity based on what were con-
sidered to be only the brightest regions. We call this
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measure Cirrocumulus. The intra-class correlation coeffi-
cients for the Altocumulus and Cirrocumulus measures of
dense area were 0.93 and 0.80 cf. 0.98 for the Cumulus
measure [19]. Figure 1 shows an example of Cumulus,
Altocumulus and Cirrocumulus measures from the same
mammogram.
Other measurements
Height and weight, and hence BMI, as well as family history
of breast cancer among first-degree relatives, menstrual
and reproductive history, and health-related behaviours
were measured as described previously [19].
Statistical analysis
We used the Box-Cox power function to transform the
mammographic density measures so that their residuals
after adjusting for age and menopausal status (due to
the design), BMI (due to negative confounding), and ma-
chine (due to technological differences) were approxi-
mately normally distributed. We found that the cube
root transformation was appropriate for the Cumulus
and Altocumulus dense area measures and a logarithmic
transformation was appropriate for the Cirrocumulus
measure. A cube root transformation was appropriate
for their respective percentage dense areas.
We evaluated the association between mammographic
density and breast cancer risk by fitting conditional lo-
gistic regression models, adjusting for machine (due to
different sampling ratios of cases and controls), with the
mammographic density measures as both continuous
and categorical variables. For the latter, we categorized
the transformed mammographic measures, adjusted for
age, menopausal status, BMI and machine, into four
levels based on the quartile distribution of subjects in
the control group, so as to be consistent with the
OPERA concept; see below.
We estimated the mammographic density risk associa-
tions as the change in log odds per standard deviation of
the age, menopausal status, BMI and machine adjusted
measures so as to produce values of OPERA [6, 20].
Therefore the risk estimates refer to change in odds per
standard deviation of mammographic density adjusted
for age, BMI, menopausal status and machine, not of
cross-sectional unadjusted mammographic density as is
conventionally done, so we derived the former measures,
standardized them, and fitted them in our models. Let r
be the correlation between two mammographic density
measures, Y1 and Y2. Since the standard deviation of Yj
adjusted for Yk is SDj||k = [(1 – r
2)]0.5, j,k = 1,2, when Yj
is fitted with Yk we multiplied the log(OR) estimate from
fitting Yj by SDj|k and then exponentiated to obtain the
appropriate OPERA (see Appendix).
Statistical analyses, including generation of the re-
ceiver operating curves and estimates of and tests of the
differences between areas under the receiver operating
curves (AUCs) using the DeLong test, and use of the
likelihood ratio criterion to test the relative goodness-of-
fit of nested models, were performed using the STATA
software package [21]. Nominal statistical significance
was, by convention, taken to be P = 0.05.
Results
Table 1 shows that the mean age at breast cancer diag-
nosis for the cases was 51.6 years and 45 % were diag-
nosed before the age of 50 years, and that 63 % of cases
and controls were premenopausal.
For both cases and controls, the Altocumulus measures
for dense and percentage dense area were 20–25 % less
than the corresponding Cumulus measures (all P < 0.001);
see Table 1. For dense area (percentage dense area), the
differences were 4.1 cm2 (3.7 %) between Cumulus and
Altocumulus measures, and 13.1 cm2 (13.4 %) between
Cumulus and Cirrocumulus measures, respectively. The
correlations were 0.84 and 0.79 for Cumulus and Alto-
cumulus, 0.63 and 0.56 for Cumulus and Cirrocumulus,
and 0.59 and 0.54 for Altocumulus and Cirrocumulus,
respectively.
Table 1 shows that, for Cumulus, Altocumulus and
Cirrocumulus, the mean of the dense and percentage dense
areas differed between cases and controls (all P < 0.05).
The statistical significance was greater for the Altocumulus
measures (all P < 0.001).
Table 2 shows there were significant risk gradients for
dense and percentage dense areas after adjusting for co-
variates (all P < 0.05). The OPERA estimates and the
AUCs were highest for Altocumulus: 1.36 (95 % confi-
dence interval (CI): 1.15–1.62, P < 0.001) for dense area
and 1.41 (1.19–1.68, P < 0.001) for percentage dense
area, respectively. The corresponding OPERA estimates
for Cumulus were 1.18 (1.01–1.39, P = 0.03) for dense
Fig. 1 Example of Cumulus (left), Altocumulus (middle) Cirrocumulus
(right) measurements from the same image using the CUMULUS
software package. For Cumulus, Altocumulus and Cirrocumulus
measures, respectively, the dense area (percentage dense area) was:
716,702 pixels (58 %); 268,374 pixels (22 %); and 51,475 pixels (4 %)
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Table 1 Characteristics of the case and control samples
Cases (n = 213)
mean (SD)
Controls (n = 630)
mean (SD)
Pa
Age at mammogram (years) 51.6 (7.6) 51.5 (7.4) 0.9
Body mass index (kg/m2) 22.5 (2.7) 22.6 (2.8) 0.8
Age at menarche (years) 14.6 (1.6) 14.6 (1.6) 0.9
Number of live birth (per child) 2.11 (0.75) 2.27 (0.91) 0.02
Menopausal status (n, %) 0.9
Premenopausal 134 (62.9) 395 (62.7)
Postmenopausal 79 (37.1) 235 (37.3)
Benign breast lump (n, %) <0.0001
Yes 34 (16.0) 36 (5.6)
No 179 (84.0) 594 (94.4)
Ever smoking (n, %) 0.08
Yes 17 (8.0) 30 (4.8)
Never 196 (92.0) 600 (95.2)
Ever alcohol consumption (n, %) 0.04
Yes 95 (44.6) 232 (36.8)
Never 118 (55.4) 398 (63.2)
Physical exercise (n, %) 0.2
More and equal 90 mins per week 85 (39.9) 223 (35.4)
Less than 90 mins per week 128 (60.1) 407 (64.6)
Ever use of hormonal therapy (n, %) 0.3
Yes 33 (15.5) 82 (13.0)
Never 180 (84.5) 548 (87.0)
Mammographic measurements
Cumulus
Dense area (cm2) 18.1 (14.9) 15.6 (11.7) 0.01
Non-dense area (cm2) 84.3 (36.0) 85.3 (34.2) 0.7
Percentage dense area 18.6 (12.3) 16.2 (10.3) 0.006
Total area (cm2) 102.3 (37.3) 100.9 (35.0) 0.6
Density thresholds (0 to 4095) 2174 (355) 2142 (343) 0.2
Altocumulus
Dense area (cm2) 14.3 (11.6) 11.4 (8.4) 0.0002
Non-dense area (cm2) 85.0 (35.3) 87.5 (34.7) 0.4
Percentage dense area 15.3 (10.8) 12.4 (8.5) 0.0001
Total area (cm2) 99.2 (36.2) 99.0 (34.8) 0.9
Density thresholds (0 to 4095) 2247 (301) 2252 (300) 0.8
Cirrocumulus
Dense area (cm2) 3.5 (3.4) 3.0 (2.3) 0.03
Non-dense area (cm2) 98.1 (41.0) 97.7 (38.8) 0.9
Percentage dense area 3.8 (2.8) 3.3 (2.4) 0.03
Total area (cm2) 101.6 (41.4) 100.8 (39.0) 0.8
Density thresholds (0 to 4095) 2559 (205) 2574 (226) 0.4
SD standard deviation
aP refers to statistical significance for the discrimination between cases and controls
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Table 2 Breast cancer risk association (OPERA) for the mammographic measurements after adjusted for age, body mass index,
menopausal status and machine (Hologic and General Electric)
Cases ORa 95 % CIb Pc AUCd (95 % CI) LL
Cumulus
Dense area
Q1e (n = 211) 47 1.00 − −
Q2e (n = 211) 54 1.18 0.76−1.84 0.5
Q3e (n = 211) 53 1.17 0.74−1.84 0.5
Q4e (n = 210) 59 1.37 0.88−2.14 0.2
OPERA 213 1.18 1.01−1.39 0.03 0.55 (0.51−0.59) -290.1865
Percent density
Q1 49 1.00 − −
Q2 49 0.98 0.63−1.54 0.9
Q3 53 1.09 0.70−1.71 0.7
Q4 62 1.4 0.90−2.17 0.1
OPERA 213 1.23 1.05−1.44 0.01 0.56 (0.52−0.61) -289.0511
Altocumulus
Dense area
Q1 43 1.00 − −
Q2 55 1.46 0.91−2.34 0.1
Q3 52 1.38 0.85−2.22 0.2
Q4 63 1.84 1.13−2.99 0.01
OPERA 1.36 1.15−1.62 <0.001 0.59 (0.55−0.63) -285.9140
Percentage density
Q1 42 1.00 − −
Q2 54 1.49 0.92−2.39 0.1
Q3 44 1.16 0.70−1.92 0.6
Q4 73 2.49 1.52−4.09 <0.001
OPERA 213 1.41 1.19−1.68 <0.001 0.60 (0.56−0.65) -284.7104
Cirrocumulus
Dense area
Q1 41 1.00 − −
Q2 58 1.61 1.01−2.58 0.05
Q3 53 1.42 0.89−2.26 0.1
Q4 61 1.78 1.11−2.86 0.02
OPERA 213 1.23 1.04−1.45 0.01 0.57 (0.52−0.61) -289.3243
Percentage density
Q1 49 1.00 − −
Q2 51 1.06 0.67−1.67 0.8
Q3 52 1.09 0.70−1.69 0.7
Q4 61 1.40 0.89−2.22 0.1
OPERA 213 1.21 1.03−1.42 0.02 0.56 (0.52−0.61) -289.6855
OPERA Odds PER Adjusted standard deviation, LL log likelihood
aOdds ratio per standard deviation of the risk factors adjusted for age, body mass index (BMI), menopausal status and machine (Hologic and General Electric)
bCI = confidence interval
cP refers to statistical significance of the odds ratio (OR) estimate
dAUCs refer to the area under the receiver operating characteristic curves for mammographic measurements after adjusted for age, body mass index, menopausal
status and machine (Hologic and General Electric)
eQuartiles (Q1-Q4) defined by distribution of the measure adjusted for age, body mass index, menopausal status and machine (Hologic and General Electric)
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area and 1.23 (1.05– 1.44, P = 0.01) for percentage dense
area, respectively. For Cirrocumulus they were 1.23
(1.04–1.45, P = 0.01) for dense area and 1.21 (1.03–1.42,
P = 0.02) for percentage dense area, respectively.
Table 3 shows the results from fitting the corresponding
Altocumulus, Cirrocumulus and Cumulus measures to-
gether. From the OPERA estimates and standard errors,
and from examining the change in log likelihood (LL) and
AUCs, it was apparent that after fitting the Altocumulus
measure the addition of the Cumulus or Altocumulus
measures did not improve the fit (P > 0.05). On the other
hand, from Tables 2 and 3 it can be seen that addition of
the Altocumulus measure gave a better fit than the Cumu-
lus or Altocumulus measures alone (P = 0.001).
Figure 2 shows that, for dense area, the AUCs were: 0.55
(95 % CI 0.51–0.59); 0.59 (0.55–0.63); 0.57 (0.52–0.61) for
the Cumulus, Altocumulus and Cirrocumulus measures,
respectively. The AUCs for the Altocumulus measures
were highly significantly greater than for the correspond-
ing Cumulus measures (P = 0.001). For dense area, the
change in AUC from 0.55 for the Cumulus measure to
0.59 for the Altocumulus measure is 80 % when compared
with the baseline AUC of 0.5 corresponding to no associ-
ation, and this is reflected in a similar change in the log
(OPERA) estimates. Similar AUCs applied to the percent-
age dense area measurements.
Discussion
We have introduced two new measures of mammographic
density, Altocumulus and Cirrocumulus (Nguyen et al:
Mammographic density defined by higher than conven-
tional pixel brightness thresholds better predicts breast
cancer risk, submitted), based on defining the mammogra-
phically ‘dense’ regions by being successively brighter, and
therefore in effect at higher pixel brightness thresholds,
than has been convention, which we call Cumulus. All
density measures discriminated between cases and con-
trols. The risk gradients and AUCs for the dense area and
percentage dense area measurements were the same as
well as their AUC.
Even though these density measures were correlated, the
Altocumulus measure performed better than the Cumulus
and Cirrocumulus measures. Moreover, when measures
were fitted together, the risk gradient for the Altocumulus
measure remained statistically significant, while the risk
gradient for the Cumulus and Cirrocumulus measures
were reduced and no longer statistically significant. This
implies that the apparent risk relationship from traditional
Cumulus measures has been confounded by the true
causes being in breast tissue seen at higher thresholds of
pixel intensity, so that the white but not bright areas on a
mammogram do not appear to be associated with risk.
Therefore, measuring density at a higher pixel thresh-
old appears to capture more risk-predicting information
than measuring at the usual threshold. This is important
for several reasons. First, in terms of clinical relevance,
we studied digital images, so our findings are relevant to
mammography as it is now and will be conducted across
most of the world. Digital mammography makes possible
automated measures that can be used to provide infor-
mation in real time. While different measures of ‘breast
density’ from digital mammograms are being developed
and applied (e.g. [22]), at the moment their only clinical
use is to identify women most prone to have a breast
cancer missed due to ‘masking’, rather than those at in-
creased risk of a future breast cancer. Our findings in-
form future developments of automated measures. They
also highlight that the two issues – masking and risk
prediction – need to be considered separately. While the
Altocumulus measures of dense area appear to be better
predictors of risk, the Cumulus measures of percent
dense area might be better predictors of masking.
Second, these findings suggest that the mammographi-
cally denser regions might be more aetiologically important
for breast cancer. The relevant tissues and biological
Table 3 Estimates of OPERA, 95 % confidence intervals (95 % CI)
from fitting multiple mammographic density measures together,
correlation between estimates (R) and log likelihood (LL) for dense
area and percentage dense area
OPERA (95 % CI) P R LL
Dense area
Cumulusa 0.73 (0.53−1.00) 0.05 -0.87 -280.34
Altocumulusa 1.83 (1.30−2.57) 0.001
Cumulusb 1.07 (0.88−1.30) 0.5 -0.6 -285.22
Cirrocumulusb 1.19 (0.97−1.47) 0.1
Altocumulusc 1.32 (1.07−1.65) 0.01 -0.62 -282.17
Cirrocumulusc 1.04 (0.85−1.29) 0.7
Cumulusd 0.71 (0.52−0.98) 0.04 -0.79 -279.97
Altocumulusd 1.77 (1.24−2.51) 0.002 -0.19
Cirrocumulusd 1.10 (0.89−1.36) 0.4 -0.22
Percentage dense area
Cumulusa 0.87 (0.66−1.14) 0.3 -0.81 -280.79
Altocumulusa 1.59 (1.18−2.14) 0.002
Cumulusb 1.15 (0.96−1.38) 0.1 -0.50 -284.74
Cirrocumulusb 1.14 (0.94−1.37) 0.2
Altocumulusc 1.39 (1.13−1.70) 0.002 -0.51 -284.65
Cirrocumulusc 1.03 (0.86−1.25) 0.7
Cumulusd 0.87 (0.66−1.15) 0.3 -0.74 -284.165
Altocumulusd 1.55 (1.14−2.10) 0.005 -0.15
Cirrocumulusd 1.05 (0.87−1.27) 0.6 -0.23
OPERA Odds PER Adjusted standard deviation
aCumulus and Altocumulus measures fitted together
bCumulus and Cirrocumulus measures fitted together
cAltocumulus and Cirrocumulus measures fitted together
dCumulus, Altocumulus and Cirrocumulus measures fitted together
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processes involved in explaining why ‘mammographic
density’ is a risk factor for breast cancer are more likely to
be in the higher density areas of the breast. If confirmed,
this is a critical observation for molecular, genetic and
other studies trying to determine the underlying biological
processes behind this phenomenon [23]. It is also import-
ant for research and translation on the prospect of using
‘mammographic density’ to better predict women for inter-
ventions or targeted screening.
Third, Altocumulus is one of the strongest yet known
risk factors for breast cancer when viewed on a popula-
tion, as distinct from individual, perspective. OPERA is
an omnibus measure for discrimination between cases
and controls similar to the area under the receiver oper-
ator curve, but has the advantage of explicitly taking into
account other risk factors. The OPERA we estimated
here of 1.4–1.5 for Altocumulus is comparable to that
for a risk score based on the current common genetic
markers (SNPs) recently found to be associated with risk
[24]. In comparison, the OPERA for rare mutations in
BRCA1 and BRCA2, combined, is only about 1.2, while
the OPERA for number of live births is close to 1.1 in a
Western population [6].
Obviously there must be an optimal threshold, at least
for a given population measured on a given machine by
the same observer. This study suggests that it is at a
higher pixel level than has been convention, at least for
digital mammograms and Korean women. While we are
not claiming that Altocumulus, as we have measured it,
is necessarily the optimal measure, we have shown that
the current threshold is not optimal. More research is
needed to clarify the situation, especially if automated
measures can be developed that allow for changing the
threshold. We are currently measuring mammographic
density across different thresholds in different popula-
tions, and using multiple observers, to try to obtain bet-
ter mammographic predictors of risk. We encourage
others to try varying thresholds to help clarify this im-
portant issue.
We are also measuring the familial aggregation of
Altocumulus and Cirrocumulus using twin and family
studies, we have done for Cumulus [17, 25, 26]. We aim
to study the associations of genetic variants known to be
associated with breast cancer risk with the Altocumulus
and Cirrocumulus measures, and compare these findings
to those for Cumulus measures (e.g. [27]).
Fig. 2 Receiver operating characteristic curve plot of sensitivity against 1-specificty for breast cancer risk, and area under the curve (AUC), for the various
dense area measures from full-field digital mammograms in terms of breast cancer risk: Health Promotion Center in the Samsung Medical Center, Korea
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There are several limitations to this study. The Cumu-
lus, Altocumulus and Cirrocumulus measures depend on
the observers. However, given that measurements are
performed blind to case-control status, the main issue is
repeatability, and all were highly repeatable, the most for
Cumulus measures. Also, the concepts of “bright” and
brightest” regions is somewhat subjective, and can vary
across observers. But we have tried to see if and how
risk prediction depends on the threshold, so the key
issue was to have measurements in effect at different
thresholds (and of course conducted blind to case-
control status) and then use OPERA, log likelihoods and
AUC to assess the relative goodness of fits.
Conclusions
This case-control study found that better discrimination
between women with and without breast cancer can be
achieved by defining mammographic density at a higher
pixel brightness threshold than conventional, at least for
Asian women. A new measure, Altocumulus, performed
better than the conventional measure, Cumulus, in pre-
dicting breast cancer risk from digital mammography
images. This suggests that the mammographically denser
(bright) regions might be more aetiologically important
for breast cancer, with implications for biological, mo-
lecular, genetic and epidemiological research and clinical
translation. More research is required to work out which
threshold is optimal and we encourage other researchers
to work on this question.
Appendix
For each transformed density measure, Y, we fitted a regres-
sion for the mean as a linear function of age and BMI and
the other fitted covariates. For individual i, E[Yi] = b0 +
bage.agei + bBMI. BMIi + b1X1i +… + bnXni, where Yi is their
observed value; E[.] represents the expected value; and agei,
BMIi, X1i, …, Xni are their age, BMIi, and other fitted covar-
iates; and b0, …, bn are the corresponding regression coeffi-
cients. We then divided the residuals, Ri = Yi – E[Yi],
by the standard deviation of the residuals, SD(Ri), to
give Y’ = Ri/SD(Ri).
The different density measures, Y’, were fitted independ-
ently and then together; the improvement in fit was
assessed using the likelihood ratio test. When we fitted two
density measures, Y1’ and Y2’, into the same model, we pre-
sented the risk estimates in terms of the change in the
standard deviation after adjusting also for the other meas-
ure, to be consistent with the OPERA concept. Let r be the
correlation between Y1’ and Y2’. Because the standard devi-
ation of Yj
’ adjusted for Yk’ is SD’ = [(1 – r
2)]0.5, for j,k = 1,2,
when Yj’ is fitted with Yk’ we multiplied the log(OR) esti-
mate from fitting Yj’ by SD’ and then exponentiated it to
obtain the appropriate OPERA. [For r = 0.6, 0.7, and 0.8,
SD’ approximately 0.8, 0.7, and 0.6, respectively].
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